drugset / Trial / NCT00723775

GSK706769/KALETRA Drug-drug Interaction Study

NCT00723775

Phase 1 Completed 17 enrolled GlaxoSmithKline
RandomizedCrossoverOpen-labelTreatment

Summary

To compare plasma GSK706769 PK following repeat administration of GSK706769 QD with and without KALETRA (LPV 400 mg/RTV 100mg) q12h

Timeline

Start
2008-07-24
Primary completion
2008-11-08
Completion
2008-11-08

Drugs

EvaluationDrugModalityDoseRoute
Subject GSK706769 Unknown Oral
Subject Ritonavir Other / unclassified 100 mg
Subject Ritonavir Other / unclassified 400 mg